Keyphrases
Ovarian Cancer
100%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Pharmacological Principles
100%
Hyperthermia
33%
Advanced Ovarian Cancer
33%
Chemotherapy
16%
Cisplatin
16%
Long-term Survival
16%
Site of Disease
16%
Recurrent Disease
16%
Knowledge Gaps
16%
PARP Inhibitor (PARPi)
16%
Survival Benefit
16%
Peritoneal Metastasis
16%
Cytoreductive Surgery
16%
Ovarian Cancer Cells
16%
Pharmacokinetic Properties
16%
Pharmacological Properties
16%
Ovarian Cancer Patients
16%
Intraperitoneal Chemotherapy
16%
Medicine and Dentistry
Ovarian Cancer
100%
Hyperthermic Intraperitoneal Chemotherapy
100%
Hyperthermia
33%
Cancer Cell
16%
Recurrent Disease
16%
Cisplatin
16%
Long Term Survival
16%
PARP Inhibitor
16%
Pharmacokinetics
16%
Peritoneum Metastasis
16%
Cytoreductive Surgery
16%
Intraperitoneal Chemotherapy
16%
Chemotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Intraperitoneal Chemotherapy
100%
Hyperthermia
28%
Chemotherapy
14%
Cisplatin
14%
Long Term Survival
14%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
14%
Recurrent Disease
14%
Peritoneum Metastasis
14%
Pharmacokinetics
14%